NCT05829798View on ClinicalTrials.gov

An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Osteoarthritis, Knee
Interventions
DEVICE

SYNOLIS VA 80/160

Single 4mL intra-articular injection of SYNOLIS VA 80/160

DEVICE

SYNOLIS VA 40/80

Single 2mL intra-articular injection of SYNOLIS VA 40/80

Trial Locations (3)

09-038

SPORTO Spółka z o.o., Lodz

02-672

Klinika Chirurgii Kolana Dr Słynarskiego, Warsaw

02-757

NZOZ Carolina Medical Center - Sport Medica S.A, Warsaw

Sponsors

Collaborators (1)

Noblewell
All Listed Sponsors
collaborator

Noblewell

INDUSTRY

lead

Aptissen SA

INDUSTRY

NCT05829798 - An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis | Biotech Hunter | Biotech Hunter